Established | 1984 |
---|---|
Director | Thomas P. Loughran Jr. [1] |
Location | Charlottesville , Virginia |
Website | https://med.virginia.edu/cancer-research/ |
University of Virginia Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center affiliated with the University of Virginia School of Medicine and the UVA Health System. [2] [3] [4]
Focused on research and education, UVA Cancer Center has more than 185 member faculty researchers supported by more than $82 million in annual funding. The center also conducts regional outreach to improve awareness of cancer risks and access to screening and treatment. [5]
UVA Cancer Center is one of 54 comprehensive centers designated by the NCI, and the first in Virginia. [6]
The University of Virginia Cancer Center was founded in 1984 and has been NCI-designated since 1987. [7] This status is reviewed every five years. [8] Its comprehensive designation became effective February 1, 2022. [9]
The center's director, Thomas P. Loughran Jr., discovered and is considered a leading expert in large granular lymphocytic (LGL) leukemia. He succeeded Michael J. Weber, who stepped down in 2013 after twelve years of service. [10]
UVA Cancer Center is funded as a partner in the federal Cancer Moonshot. [11] The initiative is led by the Biden administration and in 2022 set new goals of reducing the cancer death rate by half within 25 years while improving the lives of people with cancer and survivors. [12]
UVA Cancer Center is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). [13] It is a leader in treatment of myelodysplastic syndrome and an MDS Foundation Center of Excellence. [14]
The UVA Cancer Center's member researchers represent UVA's schools of Medicine, Nursing, Engineering and Applied Science, Education, Data Science, and the College of Arts and Sciences. Its primary research is divided into four collaborative, transdisciplinary programs: [15]
The UVA Cancer Center is a leader in research and treatment of rare blood cancers and in research and development of focused ultrasound for cancer treatment. The center is affiliated with UVA's Translational Orphan Blood Cancer Research Initiative, which pursues new therapies for rare cancers that lack the funding afforded more common cancers, and with the School of Medicine's Focused Ultrasound Cancer Immunotherapy Center. [16] [17]
UVA Cancer Center's research findings include:
UVA Cancer Center operates the LGL Leukemia Registry, the only national database and specimen bank from patients of the disease. [24] It is a member of the Oncology Research Information Exchange Network (ORIEN), a group of 16 institutions, as well as the Cooperative Human Tissue Network and the Applied Proteogenomics Organizational Learning and Outcomes (APOLLO) network.
Patients who receive cancer treatment at UVA can participate in its Partners in Discovery program by consenting to donate tumor tissue from surgeries and information about their health and treatment. Analyses of these specimens and other data is anonymously entered into the nationwide databases to support research, to further the development of personalized medicine, and to expedite access to clinical trials. [25]
The UVA Cancer Center is based at UVA Health. Outpatient treatment is provided at the Emily Couric Clinical Cancer Center (ECCCC) in Charlottesville and at satellite clinics in Albemarle and Augusta counties and in Culpeper, Virginia. [26] The ECCCC is a 150,000 square-foot facility built at a cost of $74 million. [27] It was dedicated in 2011 and named for state senator Emily Couric, who died of pancreatic cancer in 2001. [28]
The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. The NCI conducts and supports research, training, health information dissemination, and other activities related to the causes, prevention, diagnosis, and treatment of cancer; the supportive care of cancer patients and their families; and cancer survivorship.
Roswell Park Comprehensive Cancer Center is a cancer research and treatment center located in Buffalo, New York. Founded by surgeon Roswell Park in 1898, the center was the first in the United States to specifically focus on cancer research. The center is usually called Roswell Park in short. The center, which conducts clinical research on cancer as well as the development new drugs, provides advanced treatment for all forms of adult and pediatric cancer, and serves as a member of the National Comprehensive Cancer Network. Roswell Park Comprehensive Cancer Center is as of 2019, the only upstate New York facility to hold the National Cancer Institute designation of "comprehensive cancer center".
The era of cancer chemotherapy began in the 1940s with the first use of nitrogen mustards and folic acid antagonist drugs. The targeted therapy revolution has arrived, but many of the principles and limitations of chemotherapy discovered by the early researchers still apply.
Dana–Farber Cancer Institute is a comprehensive cancer treatment and research institution in Boston, Massachusetts. Dana–Farber is the founding member of Dana–Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
Houston Lee Moffitt Cancer Center & Research Institute is a nonprofit cancer treatment and research center located in Tampa, Florida. Established in 1981 by the Florida Legislature, the hospital opened in October 1986 on the University of South Florida's campus. Moffitt is one of two National Cancer Institute-designated Comprehensive Cancer Centers based in Florida. In 2021, U.S. News & World Report ranked Moffitt Cancer Center as a top 30 cancer hospital in the United States.
The University of Virginia School of Medicine is the graduate medical school of the University of Virginia. The school's facilities are on the University of Virginia grounds adjacent to Academical Village in Charlottesville, Virginia. Founded in 1819 by Thomas Jefferson, UVA SoM is the tenth oldest medical school in the United States, and is ranked 31st in research-oriented medical schools by U.S. News & World Report, and as of 2021, is ranked nineteenth in the nation in primary care. The School of Medicine confers Doctor of Medicine (M.D.) and Doctor of Philosophy (PhD) degrees, and is closely associated with both the University of Virginia Health System and Inova Health System.
City of Hope is a private, non-profit clinical research center, hospital and graduate school located in Duarte, California, United States. The center's main campus resides on 110 acres (45 ha) of land adjacent to the boundaries of Duarte and Irwindale, with a network of clinical practice locations throughout Southern California, satellite offices in Monrovia and Irwindale, and regional fundraising offices throughout the United States.
Cancer and Leukemia Group B is a cancer research cooperative group in the United States.
Large granular lymphocytic (LGL) leukemia is a chronic lymphoproliferative disorder that exhibits an unexplained, chronic elevation in large granular lymphocytes (LGLs) in the peripheral blood.
The "war on cancer" is the effort to find a cure for cancer by increased research to improve the understanding of cancer biology and the development of more effective cancer treatments, such as targeted drug therapies. The aim of such efforts is to eradicate cancer as a major cause of death. The signing of the National Cancer Act of 1971 by United States president Richard Nixon is generally viewed as the beginning of this effort, though it was not described as a "war" in the legislation itself.
The Duke Cancer Institute (DCI) is a National Cancer Institute-designated Comprehensive Cancer Center, research facility, and hospital. Founded in 1971, the center is part of the Duke University School of Medicine and Duke University Health System located in Durham, North Carolina, United States.
The UPMC Hillman Cancer Center, previously the University of Pittsburgh Cancer Institute (UPCI), is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center located in the Hillman Cancer Center in the Shadyside neighborhood of Pittsburgh, adjacent to UPMC Shadyside. The only NCI-designated cancer center in Western Pennsylvania, Hillman is composed of collaborative academic and research efforts between the University of Pittsburgh, the University of Pittsburgh Medical Center (UPMC), and Carnegie Mellon University. Hillman provides clinical cancer care to some 74,000 patients treated at its facilities at both the Hillman Cancer Center location in the Shadyside neighborhood of Pittsburgh and at UPMC-affiliated sites throughout Pennsylvania, New York, Ohio, and overseas locations. Founded in 1984, Hillman became the youngest cancer center in history to achieve NCI-designation. As of 2007, Hillman had received nearly $200 million in funding from the National Cancer Institute, which ranks it as one of the top ten cancer research institutes.
The University of Chicago Medicine Comprehensive Cancer Center is a collaborative cancer research center based in Hyde Park, Chicago, United States. The Comprehensive Cancer Center is affiliated with the University of Chicago.
The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is a cancer treatment, research and education institution with six locations in the St. Louis area. Siteman is the only cancer center in Missouri and within 240 miles of St. Louis to be designated a Comprehensive Cancer Center by the National Cancer Institute (NCI). Siteman is also the only area member of the National Comprehensive Cancer Network, a nonprofit alliance of 32 cancer centers dedicated to improving the quality and effectiveness of cancer care.
Gibbs Cancer Center & Research Institute is a cancer treatment and research facility in Upstate South Carolina. Gibbs Cancer Center is associated with the NCI Community Cancer Centers Program and the Medical University of South Carolina. Gibbs headquarters is located on the campus of the Spartanburg Medical Center (SRMC) in Spartanburg, SC.
Thomas P. Loughran, Jr. is an American physician-scientist who specializes in cancer research and treatment. He became director of the University of Virginia Cancer Center, F. Palmer Weber-Smithfield Foods Professor of Oncology Research and Professor of Medicine at the University of Virginia on August 15, 2013. Between 2003 and 2013, Loughran served as the founding director of the Penn State Hershey Cancer Institute and professor of medicine at the Penn State College of Medicine. His previous appointments included program leader of hematologic malignancies at the H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida, associate director of the Bone Marrow Transplant Program at SUNY Health Science Center and chief of hematology at the Syracuse Veteran's Affairs Medical Center in Syracuse, New York. Loughran completed his fellowship in medical oncology in 1985 at the Fred Hutchinson Cancer Research Center in Seattle, Washington under direction of Nobel Laureate E. Donnall Thomas. He remained on faculty there for seven years. Loughran earned his medical degree from Hahnemann Medical School in Philadelphia in 1979.
This is a historical timeline of the development and progress of cancer treatments, which includes time of discovery, progress, and approval of the treatments.
Azra Raza is the Chan Soon-Shiong Professor of Medicine and Director of Myelodysplastic Syndrome (MDS) Center at Columbia University. She has previously held positions at Roswell Park Comprehensive Cancer Center, University of Cincinnati, Rush University, and the University of Massachusetts. Raza's research focuses on myelodysplastic syndrome and acute myeloid leukemia.
UVA Children's Hospital is a nationally ranked, acute care children's hospital in Charlottesville, Virginia. It is affiliated with the University of Virginia School of Medicine. The hospital features 112 pediatric beds. The hospital provides comprehensive pediatric specialties and subspecialties to infants, children, teens, and young adults aged 0–21 throughout the region. The hospital also sometimes treats adults that require pediatric care. The hospital has a rooftop helipad to transport critical pediatric cases. The hospital features a regional pediatric intensive-care unit and a level IV neonatal intensive care unit.